Health

In a major collaborative effort to head off a global "silent pandemic," the Bill & Melinda Gates Foundation, the Novo...

Healthcare diagnostics demand rises significantly in early 2026, driven by aging populations, preventive care emphasis, and advancements in point-of-care testing...

Healthcare staffing demand rises in early 2026 indicators, with hospitals and clinics increasing recruitment for nurses, physicians, and allied professionals...

Health stocks gain momentum in early January 2026 trading, buoyed by positive vaccine developments and analyst outlooks highlighting resilient demand...

The World Health Organization (WHO) highlights significant global disease control milestones in 2025, demonstrating major progress in eliminating and reducing...

The Trump administration secures groundbreaking drug pricing agreements with major pharmaceutical companies, aiming to significantly lower costs for Medicaid beneficiaries...

Kyoto University Hospital's September 2025 launch of the world's first human trial for tooth-regrowth drug TRG035—targeting USAG-1 inhibition—ushers regenerative dentistry's...

The FDA's December 2025 approval of deuruxolitinib (Leqselvi®) as a first-line oral therapy for moderate-to-severe alopecia areata (AA) in adults...

The quest for anti-aging elixirs pivots to immunology's vanguard: CAR T-cell therapies, once cancer's scourge, now target senescence—the cellular "zombie"...

Stanford's PRIMAvera trial in October 2025 heralds vision's return for 5 million GA-AMD sufferers, with photovoltaic retinal implants—2x2mm, 30µm thick—enabling...